We need tools for dealing with bioterrorism when it occurs, and among these tools are pharmaceuticals.

Will DHHS dealwith the maker of the leading anthrax treatment to increase the supply of the drug while lowering its price do more harm than good?

Bioterrorism attacks using anthrax occurred almost simultaneously with shortages of widely used vaccines. Because vaccines are essential to biodefense, these two disturbing episodes are ominously linked. The topic of the morning discussion will be whether our recent vaccine shortage is a unique, one-time problem or rather caused by systemic obstacles...

The recent tsunami in Southeast Asia showed how a relatively inexpensive early warning system could have saved tens of thousands of lives. Tsunamis, of course, are only one of many potential catastrophes that could afflict mankind. In this Joint Center lecture, Judge Richard Posner examines a host of catastrophes that...

Considers the impact of political intrusions on drug development and the consequence for America's biodefense.

Vaccine development requires partnership between government and industry because of the different resources, perspectives, and skills that each brings to the table.

While the world stands transfixed by the specter of a pandemic flu, a very different threat, bioterrorism, remains largely unaddressed.